Table 2 The use of PROMs in different settings within knee and hip OA
Type of PROMa | Surgical: n (%) | Non-surgical: n (%) | Both surgical and non-surgical: n (%) | Unspecified treatment: n (%) | Total: n (%) |
|---|---|---|---|---|---|
Generic | |||||
 EQ-5D | 52 (43.7) | 7 (20.6) | 3 (33.3) | 1 (6.7) | 63 (35.6) |
 SF-12 | 39 (32.8) | 9 (26.5) | 1 (11.1) | 4 (26.7) | 53 (29.9) |
 SF-36 | 27 (22.7) | 7 (20.6) | 5 (55.6) | 7 (46.7) | 46 (26.0) |
 PROMIS | 0 (0) | 8 (23.5) | 0 (0) | 3 (20.0) | 11 (6.2) |
 Otherb | 1 (0.8) | 3 (8.8) | 0 (0) | 0 (0) | 4 (2.3) |
 Subtotal | 119 (100) | 34 (100) | 9 (100) | 15 (100) | 177 (100) |
Disease-specific | |||||
 WOMAC | 70 (22.3) | 23 (39.7) | 9 (34.6) | 20 (31.3) | 122 (26.4) |
 KOOS | 37 (11.8) | 16 (27.6) | 5 (19.2) | 14 (21.9) | 72 (15.6) |
 OKS | 57 (18.2) | 3 (5.2) | 2 (7.7) | 4 (6.3) | 66 (14.3) |
 KSS | 45 (14.3) | 1 (1.7) | 0 (0) | 2 (3.1) | 48 (10.4) |
 OHS | 37 (11.8) | 0 (0) | 2 (7.7) | 1 (1.6) | 40 (8.7) |
 HOOS | 24 (7.6) | 3 (5.2) | 3 (11.5) | 5 (7.8) | 35 (7.6) |
 HHS | 19 (6.1) | 0 (0) | 4 (15.4) | 3 (4.7) | 26 (5.6) |
 FJS | 17 (5.4) | 0 (0) | 0 (0) | 0 (0) | 17 (3.7) |
 Otherc | 8 (2.5) | 12 (20.7) | 1 (3.8) | 15 (23.4) | 36 (7.8) |
 Subtotal | 314 (100) | 58 (100) | 26 (100) | 64 (100) | 462 (100) |
Domain-specific | |||||
 VAS | 16 (88.9) | 9 (69.2) | 2 (100) | 6 (50) | 33 (73.3) |
 Otherd | 2 (11.1) | 4 (30.8) | 0 (0) | 6 (50) | 12 (26.7) |
 Subtotal | 18 (100) | 13 (100) | 2 (100) | 12 (100) | 45 (100) |
Total | 451 | 105 | 37 | 91 | 684 |